1. Home
  2. KNSA vs TRMD Comparison

KNSA vs TRMD Comparison

Compare KNSA & TRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • TRMD
  • Stock Information
  • Founded
  • KNSA 2015
  • TRMD 1889
  • Country
  • KNSA United Kingdom
  • TRMD United Kingdom
  • Employees
  • KNSA N/A
  • TRMD N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • TRMD Marine Transportation
  • Sector
  • KNSA Health Care
  • TRMD Consumer Discretionary
  • Exchange
  • KNSA Nasdaq
  • TRMD Nasdaq
  • Market Cap
  • KNSA 2.1B
  • TRMD 1.7B
  • IPO Year
  • KNSA 2018
  • TRMD N/A
  • Fundamental
  • Price
  • KNSA $27.53
  • TRMD $16.72
  • Analyst Decision
  • KNSA Strong Buy
  • TRMD Buy
  • Analyst Count
  • KNSA 5
  • TRMD 1
  • Target Price
  • KNSA $38.80
  • TRMD $23.00
  • AVG Volume (30 Days)
  • KNSA 1.1M
  • TRMD 934.0K
  • Earning Date
  • KNSA 07-22-2025
  • TRMD 08-14-2025
  • Dividend Yield
  • KNSA N/A
  • TRMD 23.97%
  • EPS Growth
  • KNSA N/A
  • TRMD N/A
  • EPS
  • KNSA N/A
  • TRMD 4.74
  • Revenue
  • KNSA $481,166,000.00
  • TRMD $1,444,200,000.00
  • Revenue This Year
  • KNSA $37.21
  • TRMD N/A
  • Revenue Next Year
  • KNSA $5.32
  • TRMD N/A
  • P/E Ratio
  • KNSA N/A
  • TRMD $3.52
  • Revenue Growth
  • KNSA 59.45
  • TRMD N/A
  • 52 Week Low
  • KNSA $17.38
  • TRMD $13.60
  • 52 Week High
  • KNSA $30.69
  • TRMD $40.47
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 54.29
  • TRMD 47.97
  • Support Level
  • KNSA $27.62
  • TRMD $17.19
  • Resistance Level
  • KNSA $29.23
  • TRMD $19.41
  • Average True Range (ATR)
  • KNSA 1.03
  • TRMD 0.53
  • MACD
  • KNSA -0.21
  • TRMD -0.07
  • Stochastic Oscillator
  • KNSA 46.99
  • TRMD 18.50

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About TRMD TORM plc

TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.

Share on Social Networks: